Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity


The indole alkaloid ibogaine (NIH 10567, Endabuse) is currently being examined for its potential utility in the treatment of cocaine and opioid addiction. However, a clearly defined molecular mechanism of action for ibogaine's putative anti-addictive properties has not been delineated. Radioligand binding assays targeting over 50 distinct neurotransmitter… (More)
DOI: 10.1007/BF02245936

7 Figures and Tables


  • Presentations referencing similar topics